Skip to main content
Signal8

HAVN Life Sciences Inc. (HAVLF)

HAVN Life Sciences Inc. is a biotechnology firm that specializes in the research and innovation of psychotropic compounds derived from botanical and fungal organisms. The company is also dedicated to establishing standardized, quality-controlled methodologies for extracting these psychoactive molecules, with a specific focus on Psilocybe mushroom species and their key constituents such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health products utilizing unregulated ingredients. Founded in 2020, HAVN Life Sciences' operations are headquartered in Richmond, Canada.

Sector: Biotechnology

Industry: Biotechnology

HAVN Life Sciences Inc. logo

HAVN Life Sciences Inc.

OTC:HAVLFHealthcare
CLOSED
Mkt Cap-
EV-
Float23.1M
O/S25.65M
VOL116 sh
RVOL1.00×
Inst Own-
Net Cash/Sh+$0.02
Dilution
Financials Summary
Revenue$194K
Net Income-$15.71M
Total Assets$2.84M
Free Cash Flow-$5.58M
Debt & Equity
Debt 11%
Equity 89%
Total Debt$273K
Total Equity$2.2M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:30Reverse split
    Aug 3, 202230 shares → 1
Balance Sheet Details
Assets$2.84M
Liabilities$643K
Accounts Receivable$106K
Accounts Payable$225K
Inventory$804K
PP&E (Net)$249K
Goodwill$0
Intangible Assets$654K
Income Statement
PeriodFY 2022FY 2021FY 2020
CurrencyUSDUSDUSD
Period Ending2022-04-302021-04-302020-04-30
Revenue$194K$0$0
YoY Growth---
Cost of Revenue$131K$3.22M$0
Gross Profit$63K-$3.22M$0
Gross Margin32.4%--
Research and Development$459K$233K$0
Selling, General, and Administrative$6.07M$13.59M$29K
Other$403K$3.22M$0
Total Operating Expenses$6.93M$17.04M$29K
Operating Income (EBIT)-$6.87M-$21.25M-$28K
Operating Margin-3548.4%--
Interest Expense$45K$12K$0
Interest Income$21K$0$384
Other Income (Expense)-$8.84M-$19K$0
Income Before Tax (EBT)-$15.71M-$21.27M-$28K
Income Tax Expense$0$0-$144K
Net Income-$15.71M-$21.27M-$28K
Net Income Margin-8117.8%--
Supplementary Data
EPS-5.25-8.47-0.02
Diluted EPS-5.25-8.47-0.02
Weighted Average OS4.28M3.59M2.23M
EBITDA-$5.18M-$10.39M$0
EBITDA Margin-2677.3%--
Balance Sheet
PeriodFY 2022FY 2021FY 2020
CurrencyUSDUSDUSD
Period Ending2022-04-302021-04-302020-04-30
Assets
Current Assets
Cash and Cash Equivalents$739K$6.58M$1.13M
Short-Term Investments$0$0$0
Cash and Short-Term Investments$739K$6.58M$1.13M
Accounts Receivable$106K$147K$0
Inventory$804K$252K-$175K
Other Current Assets$118K$0$351K
Total Current Assets$1.92M$7.43M$1.36M
Long-Term Assets
Property, Plant & Equipment Net$249K$477K$0
Goodwill$0$0$0
Intangible Assets$654K$2.05M$0
Long-Term Investments$0$0$0
Deferred Tax Assets$0$0$0
Other Long-Term Assets$17K$13K$0
Total Long-Term Assets$920K$2.54M$0
Other Assets$0$0$0
Total Assets$2.84M$9.97M$1.36M
Liabilities
Current Liabilities
Accounts Payable$225K$374K$29K
Short-Term Debt$0$0$0
Current Income Tax Payable$0$0$0
Current Unearned Revenue$0$0$0
Other Current Liabilities$99K$0$0
Total Current Liabilities$426K$500K$29K
Long-Term Liabilities
Long-Term Debt$0$0$0
Long-Term Unearned Revenue$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0
Other Long-Term Liabilities$0$0$0
Total Long-Term Liabilities$217K$228K$0
Other Liabilities$0$0$0
Total Liabilities$643K$728K$29K
Stockholders' Equity
Preferred Stock$0$0$0
Common Stock$34.41M$25.9M$1.35M
Retained Earnings-$37.01M-$21.3M-$28K
Comprehensive Income & Other$4.39M$4.28M$14K
Other Stockholders' Equity$4.8M$4.64M$14K
Total Equity$2.2M$9.24M$1.33M
Minority Interest$0$0$0
Total Liabilities and Equity$2.84M$9.97M$1.36M
Supplementary Data
Total Debt$273K$319K$0
Net Debt-$466K-$6.26M-$1.13M
Cash Flow Statement
PeriodFY 2022FY 2021FY 2020
CurrencyUSDUSDUSD
Period Ending2022-04-302021-04-302020-04-30
Operating Activities
Net Income-$15.71M-$21.27M-$28K
Depreciation & Amortization$403K$3.22M$345K
Deferred Income Tax$8.8M$0$0
Stock-Based Compensation$1.25M$6.4M$0
Changes in Working Capital:
  Accounts Receivable-$76K-$145K$0
  Inventory$0$0$0
  Accounts Payable$0$0$0
  Other Working Capital-$299K-$286K-$630
Total Working Capital Change-$375K-$431K-$24K
Other Non-Cash Items$118K$4.78M-$346K
Net Cash from Operating-$5.51M-$7.3M-$53K
Investing Activities
Capital Expenditures-$72K-$23K$0
Acquisitions-$840K-$242K$0
Purchases of Investments$0$0$0
Sales of Investments$0$0$0
Other Investing Activities-$509K-$13K-$175K
Net Cash from Investing-$1.42M-$278K-$175K
Financing Activities
Debt Repaid$92K$23K-
Common Stock Issuance$1.4M$9.89M$1.35M
Common Stock Repurchases$0$0$0
Dividends Paid$0$0$0
Other Financing Activities-$216K$3.15M$14K
Net Cash from Financing$1.09M$13.02M$1.36M
Forex Effect$0$0$0
Net Change in Cash-$5.84M$5.45M$1.13M
Supplementary Data
Operating Cash Flow-$5.51M-$7.3M-$53K
Capital Expenditure-$72K-$23K$0
Free Cash Flow-$5.58M-$7.32M-$53K
Cash at Beginning$6.58M$1.13M-$63
Cash at End$739K$6.58M$1.13M